bims-hummad Biomed News
on Humanised mouse models of autoimmune disorders
Issue of 2026–02–22
one paper selected by
Maksym V. Kopanitsa, Charles River Laboratories



  1. Cell Rep. 2026 Feb 13. pii: S2211-1247(26)00055-0. [Epub ahead of print]45(2): 116977
      Profound differences in T cell receptor (TCR) repertoire and functional profiles between human and murine γδ T cells pose significant challenges for translational γδ T cell research. Therefore, we generated humanized immune system (HIS) NBSGW (NOD,B6.PrkdcscidIl2rγ-/-KitW41/W41) mice reconstituted with human fetal liver CD34+ hematopoietic stem and progenitor cells (HSPCs) enabling evaluation of human γδ T cells in vivo. The HIS mice accurately recapitulate the TCR-associated thymic programming of human γδ T cells-alongside αβ T cell development-and their peripheral effector functions, including the generation of phosphoantigen-reactive Vγ9Vδ2 T cells uniquely found in humans. Moreover, terminal deoxynucleotidyl transferase (TdT) is identified as a key regulator of type 3 Vδ2 T cell development. These findings demonstrate that HIS mice are a powerful model to screen human γδ T cell-targeting immunotherapies and to obtain mechanistic insights into human γδ T cell biology.
    Keywords:  CP: immunology; DNTT; Vgamma9Vdelta2; development; gamma delta; gammadelta; human; humanized; mouse model; phosphoantigen; thymus
    DOI:  https://doi.org/10.1016/j.celrep.2026.116977